It may also lead to improved therapies to fight
sleeping sickness; current medications used to
combat the disease have improved over the past decade but still include an old arsenic - based drug that kills between 5 and 10 percent of the people receiving treatment, said the study's senior author Stephen Hajduk, a professor of biochemistry and molecular biology in the UGA Franklin College of Arts and Sciences.